A detailed history of Strategic Financial Services, Inc, transactions in Abb Vie Inc. stock. As of the latest transaction made, Strategic Financial Services, Inc, holds 4,052 shares of ABBV stock, worth $729,360. This represents 0.05% of its overall portfolio holdings.

Number of Shares
4,052
Previous 3,854 5.14%
Holding current value
$729,360
Previous $661,000 21.03%
% of portfolio
0.05%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $32,440 - $39,467
198 Added 5.14%
4,052 $800,000
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $30,648 - $35,790
-198 Reduced 4.89%
3,854 $661,000
Q1 2024

May 07, 2024

SELL
$159.82 - $182.1 $5,114 - $5,827
-32 Reduced 0.78%
4,052 $737,000
Q3 2023

Nov 06, 2023

SELL
$133.59 - $154.65 $74,008 - $85,676
-554 Reduced 11.94%
4,084 $608,000
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $14,178 - $17,644
107 Added 2.36%
4,638 $624,000
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $37,758 - $45,282
-273 Reduced 5.68%
4,531 $732,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $76,241 - $96,927
554 Added 13.04%
4,804 $736,000
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $263 - $327
2 Added 0.05%
4,250 $689,000
Q4 2021

Feb 15, 2022

BUY
$107.43 - $135.93 $8,379 - $10,602
78 Added 1.87%
4,248 $575,000
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $1,023 - $1,126
-10 Reduced 0.24%
4,170 $451,000
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $9,497 - $12,823
-118 Reduced 2.75%
4,180 $448,000
Q3 2020

Nov 16, 2020

SELL
$85.91 - $100.83 $90,463 - $106,173
-1,053 Reduced 19.68%
4,298 $376,000
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $10,819 - $13,537
-150 Reduced 2.73%
5,351 $474,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $13,074 - $16,712
199 Added 3.75%
5,501 $400,000
Q4 2018

Feb 11, 2019

BUY
$77.85 - $96.01 $50,913 - $62,790
654 Added 14.07%
5,302 $489,000
Q3 2018

Oct 25, 2018

SELL
$88.91 - $98.84 $42,676 - $47,443
-480 Reduced 9.36%
4,648 $440,000
Q2 2018

Aug 06, 2018

BUY
$89.78 - $106.23 $13,467 - $15,934
150 Added 3.01%
5,128 $475,000
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $13,249 - $17,742
-144 Reduced 2.81%
4,978 $471,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,122
5,122 $371,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Strategic Financial Services, Inc, Portfolio

Follow Strategic Financial Services, Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Financial Services, Inc,, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Financial Services, Inc, with notifications on news.